Posted by MrMed on June 18 2024 at 09:37 AM
public
Pulmonary arterial hypertension (PAH) is a serious condition characterised by high blood pressure in the arteries that supply the lungs. This elevated pressure puts a strain on the heart and can ...
The latest report by IMARC Group, titled “GCC Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals...
The latest report by IMARC Group, titled “GCC Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals...
Propelled by developments in medical technology, rising respiratory disease prevalence, and an increasing demand for minimally invasive procedures, the global interventional pulmonary market has ex...
Pulmonary drugs refers to medicines used for the treatment of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. These drugs ar...
Pulmonary Arterial Hypertension Market Overview
Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Pulmonary Arterial Hypertension Market”....
Pulmonary Arterial Hypertension Market Overview
Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “Pulmonary Arterial Hypertension Market”. The...
